Report cover image

Global Latanoprost Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 181 Pages
SKU # APRC20278525

Description

Summary

According to APO Research, The global Latanoprost market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Latanoprost is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Latanoprost is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Latanoprost is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Latanoprost is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Latanoprost include Apotex, CR Zizhu, Taj Pharma, Pfizer, Mylan, Novartis and Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Latanoprost, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Latanoprost, also provides the sales of main regions and countries. Of the upcoming market potential for Latanoprost, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latanoprost sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Latanoprost market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Latanoprost sales, projected growth trends, production technology, application and end-user industry.

Latanoprost Segment by Company

Apotex
CR Zizhu
Taj Pharma
Pfizer
Mylan
Novartis
Teva
Latanoprost Segment by Type

Brand Drug
Generic Drug
Latanoprost Segment by Application

Open-angle Glaucoma
Close-angle Glaucoma
Latanoprost Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Latanoprost market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

181 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Latanoprost Market Size, 2020 VS 2024 VS 2031
1.3 Global Latanoprost Market Size Estimates and Forecasts (2020-2031)
1.4 Global Latanoprost Sales Estimates and Forecasts (2020-2031)
1.5 Global Latanoprost Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Latanoprost Market Dynamics
2.1 Latanoprost Industry Trends
2.2 Latanoprost Industry Drivers
2.3 Latanoprost Industry Opportunities and Challenges
2.4 Latanoprost Industry Restraints
3 Latanoprost Market by Manufacturers
3.1 Global Latanoprost Revenue by Manufacturers (2020-2025)
3.2 Global Latanoprost Sales by Manufacturers (2020-2025)
3.3 Global Latanoprost Average Sales Price by Manufacturers (2020-2025)
3.4 Global Latanoprost Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Latanoprost Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Latanoprost Manufacturers, Product Type & Application
3.7 Global Latanoprost Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Latanoprost Market CR5 and HHI
3.8.2 Global Top 5 and 10 Latanoprost Players Market Share by Revenue in 2024
3.8.3 2024 Latanoprost Tier 1, Tier 2, and Tier 3
4 Latanoprost Market by Type
4.1 Latanoprost Type Introduction
4.1.1 Brand Drug
4.1.2 Generic Drug
4.2 Global Latanoprost Sales by Type
4.2.1 Global Latanoprost Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Latanoprost Sales by Type (2020-2031)
4.2.3 Global Latanoprost Sales Market Share by Type (2020-2031)
4.3 Global Latanoprost Revenue by Type
4.3.1 Global Latanoprost Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Latanoprost Revenue by Type (2020-2031)
4.3.3 Global Latanoprost Revenue Market Share by Type (2020-2031)
5 Latanoprost Market by Application
5.1 Latanoprost Application Introduction
5.1.1 Open-angle Glaucoma
5.1.2 Close-angle Glaucoma
5.2 Global Latanoprost Sales by Application
5.2.1 Global Latanoprost Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Latanoprost Sales by Application (2020-2031)
5.2.3 Global Latanoprost Sales Market Share by Application (2020-2031)
5.3 Global Latanoprost Revenue by Application
5.3.1 Global Latanoprost Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Latanoprost Revenue by Application (2020-2031)
5.3.3 Global Latanoprost Revenue Market Share by Application (2020-2031)
6 Global Latanoprost Sales by Region
6.1 Global Latanoprost Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Latanoprost Sales by Region (2020-2031)
6.2.1 Global Latanoprost Sales by Region (2020-2025)
6.2.2 Global Latanoprost Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Latanoprost Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Latanoprost Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Latanoprost Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Latanoprost Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Latanoprost Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Latanoprost Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Latanoprost Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Latanoprost Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Latanoprost Revenue by Region
7.1 Global Latanoprost Revenue by Region
7.1.1 Global Latanoprost Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Latanoprost Revenue by Region (2020-2025)
7.1.3 Global Latanoprost Revenue by Region (2026-2031)
7.1.4 Global Latanoprost Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Latanoprost Revenue (2020-2031)
7.2.2 North America Latanoprost Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Latanoprost Revenue (2020-2031)
7.3.2 Europe Latanoprost Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Latanoprost Revenue (2020-2031)
7.4.2 Asia-Pacific Latanoprost Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Latanoprost Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Latanoprost Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Apotex
8.1.1 Apotex Comapny Information
8.1.2 Apotex Business Overview
8.1.3 Apotex Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Apotex Latanoprost Product Portfolio
8.1.5 Apotex Recent Developments
8.2 CR Zizhu
8.2.1 CR Zizhu Comapny Information
8.2.2 CR Zizhu Business Overview
8.2.3 CR Zizhu Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 CR Zizhu Latanoprost Product Portfolio
8.2.5 CR Zizhu Recent Developments
8.3 Taj Pharma
8.3.1 Taj Pharma Comapny Information
8.3.2 Taj Pharma Business Overview
8.3.3 Taj Pharma Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Taj Pharma Latanoprost Product Portfolio
8.3.5 Taj Pharma Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Latanoprost Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Mylan Latanoprost Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Novartis
8.6.1 Novartis Comapny Information
8.6.2 Novartis Business Overview
8.6.3 Novartis Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Novartis Latanoprost Product Portfolio
8.6.5 Novartis Recent Developments
8.7 Teva
8.7.1 Teva Comapny Information
8.7.2 Teva Business Overview
8.7.3 Teva Latanoprost Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Teva Latanoprost Product Portfolio
8.7.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Latanoprost Value Chain Analysis
9.1.1 Latanoprost Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Latanoprost Production Mode & Process
9.2 Latanoprost Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Latanoprost Distributors
9.2.3 Latanoprost Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.